Skip to search formSkip to main contentSkip to account menu

AN-9

Known as: AN 9, AN9 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Anthracyclines are frequently used to treat many cancers including triple negative breast cancer, which is commonly observed in… 
2007
2007
The anthracycline group of compounds is extensively used in current cancer chemotherapy regimens and is classified as… 
2006
2006
Paper presented at the International Lupin Association Conference (5th : 1988 : Poznan, Poland). 
2005
2005
A novel butyric acid derivative, pivaloyloxymethyl butyrate, AN-9, was previously shown to be a potent differentiating agent. AN… 
2004
2004
The ability of mitoxantrone to form DNA adducts was investigated in a series of human tumor cell lines consisting of human… 
2004
2004
The anti-proliferative effects of pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) derivative with potent tumor… 
1995
1995
Convergences of closed forms, energy forms or energy functions have been studied by many authors (see e.g. [l]-[3], [5]-[8]). It… 
1994
1994
A study of the effects of three differentiating agents, butyric acid, retinoic acid and cytosine arabinoside on proliferation and… 
1985
1985
A total of 339 strains of the Mycobacterium avium-intracellulare-scrofulaceum complex were phage typed using our previously… 
1982
1982
The effect of hydroxylation genes on the hydroxylation of intermediates of flavonoid biosynthesis in Petunia hybrida is reported…